Target intelligence / Profile preview

Tumor suppressing subtransferable candidate 2 pseudogene (TSSC2)

Target
TSSC2
Molecular classification
Pseudogene
01

Overview

TSSC2 is classified as a human pseudogene, meaning it shares high sequence similarity with a protein-coding gene but no longer produces a functional protein or is not known to be translated[3][4][7][12]. Located on chromosome 11p15.4, it is a transcribed, unprocessed pseudogene, meaning it may be transcribed into RNA but lacks functional protein coding capability[3][7][9][12]. TSSC2 has no known protein product, molecular function, or established biological or therapeutic role. There is no evidence to date supporting its function as a drug target, biomarker, or contributor to disease; it is not considered a druggable receptor, enzyme, transporter, or signaling molecule[1][3][4][7][12]. The abbreviation "ALG1 pseudogene" in some aliases refers to sequence similarity with asparagine-linked glycosylation 1 (ALG1), but TSSC2 is not itself an active enzyme or receptor.

Other names
Tumor-suppressing STF cDNA 2asparagine-linked glycosylation 1 homolog (yeast, beta-1,4-mannosyltransferase) (ALG1) pseudogene

Beyond the preview

Go deeper on Tumor suppressing subtransferable candidate 2 pseudogene (TSSC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor suppressing subtransferable candidate 2 pseudogene (TSSC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call